243 related articles for article (PubMed ID: 19815198)
1. Serum and follicular endocrine profile is different in modified natural cycles than in cycles stimulated with gonadotropin and gonadotropin-releasing hormone antagonist.
Jancar N; Virant-Klun I; Bokal EV
Fertil Steril; 2009 Dec; 92(6):2069-71. PubMed ID: 19815198
[TBL] [Abstract][Full Text] [Related]
2. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
Lee JR; Kim SH; Kim SM; Jee BC; Ku SY; Suh CS; Choi YM; Kim JG; Moon SY
Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
[TBL] [Abstract][Full Text] [Related]
3. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes.
Papanikolaou EG; Bourgain C; Kolibianakis E; Tournaye H; Devroey P
Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618
[TBL] [Abstract][Full Text] [Related]
4. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
Elgindy EA; El-Haieg DO; El-Sebaey A
Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
[TBL] [Abstract][Full Text] [Related]
5. Anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation and optimal timing of measurement for outcome prediction.
Lee JR; Kim SH; Kim SM; Jee BC; Ku SY; Suh CS; Choi YM; Kim JG; Moon SY
Hum Reprod; 2010 Oct; 25(10):2597-604. PubMed ID: 20729237
[TBL] [Abstract][Full Text] [Related]
6. Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection.
Wunder DM; Guibourdenche J; Birkhäuser MH; Bersinger NA
Fertil Steril; 2008 Dec; 90(6):2203-10. PubMed ID: 18291376
[TBL] [Abstract][Full Text] [Related]
7. Clinical and endocrine effects of ovulation induction with FSH and hCG supplementation in low responders in the midfollicular phase. A pilot study.
Ferrari B; Barusi L; Coppola F
J Reprod Med; 2002 Feb; 47(2):137-43. PubMed ID: 11883353
[TBL] [Abstract][Full Text] [Related]
8. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
[TBL] [Abstract][Full Text] [Related]
9. [Hormone profile and follicle development in ovarian stimulation treatment for in vitro fertilization. II. Prolactin, estradiol and progesterone profile].
Sudik R; Fliess FR; Kunkel S
Zentralbl Gynakol; 1989; 111(9):567-80. PubMed ID: 2500795
[TBL] [Abstract][Full Text] [Related]
10. Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: impact of gonadotropin-releasing hormone agonists versus antagonists.
Saadat P; Boostanfar R; Slater CC; Tourgeman DE; Stanczyk FZ; Paulson RJ
Fertil Steril; 2004 Jul; 82(1):167-71. PubMed ID: 15237007
[TBL] [Abstract][Full Text] [Related]
11. [Steroid and protein hormone concentrations in serum and follicular fluid after stimulation for in vitro fertilization].
Zech H; Weiss P; Fritzsche H; Zech J; Daxenbichler G
Geburtshilfe Frauenheilkd; 1992 Aug; 52(8):483-6. PubMed ID: 1397945
[TBL] [Abstract][Full Text] [Related]
12. Follicular fluid hormone concentrations during controlled ovarian hyperstimulation using gonadotropin preparations with different FSH/LH ratios. I. Comparison of an FSH-dominant and a purified FSH preparation.
Duijkers IJ; Willemsen WN; Hollanders HM; Hamilton CJ; Thomas CM; Vemer HM
Int J Fertil Womens Med; 1997; 42(6):426-30. PubMed ID: 9459088
[TBL] [Abstract][Full Text] [Related]
13. Effects of gonadotropin-releasing hormone agonist/recombinant follicle-stimulating hormone versus gonadotropin-releasing hormone antagonist/recombinant follicle-stimulating hormone on follicular fluid levels of adhesion molecules during in vitro fertilization.
Fornaro F; Cobellis L; Mele D; Tassou A; Badolati B; Sorrentino S; De Lucia D; Colacurci N
Fertil Steril; 2007 Jan; 87(1):39-47. PubMed ID: 17084393
[TBL] [Abstract][Full Text] [Related]
14. Altered vascular endothelial growth factor expression during GnRH antagonist protocol in women of reproductive age with normal baseline hormone profiles.
Koo YA; Lee B; Park HJ; Choi J; Lee E; Choi D
Fertil Steril; 2009 Mar; 91(3):744-8. PubMed ID: 18321491
[TBL] [Abstract][Full Text] [Related]
15. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
[TBL] [Abstract][Full Text] [Related]
16. Effects of ovarian high response on implantation and pregnancy outcome during controlled ovarian hyperstimulation (with GnRH agonist and rFSH).
Chen QJ; Sun XX; Li L; Gao XH; Wu Y; Gemzell-Danielsson K; Cheng LN
Acta Obstet Gynecol Scand; 2007; 86(7):849-54. PubMed ID: 17611831
[TBL] [Abstract][Full Text] [Related]
17. The relation of serum and follicular fluid leptin and ovarian steroid levels in response to induction of ovulation in in vitro fertilization cycles.
Gürbüz B; Yalti S; Ficicioglu C; Taşdemir S
Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):214-8. PubMed ID: 15653206
[TBL] [Abstract][Full Text] [Related]
18. Endocrine modifications associated with final oocyte maturation with gonadotropin-releasing hormone agonists vs. human chorionic gonadotropin in women undergoing intrauterine insemination.
Díaz I; Guillén A; Pacheco A; Requena A; Garcia-Velasco JA
J Reprod Med; 2008 Jan; 53(1):33-9. PubMed ID: 18251359
[TBL] [Abstract][Full Text] [Related]
19. Plasma hormones in human gonadotropin induced ovulation.
Wu CH
Obstet Gynecol; 1977 Mar; 49(3):308-13. PubMed ID: 840459
[TBL] [Abstract][Full Text] [Related]
20. Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization.
Kovacs P; Kovats T; Bernard A; Zadori J; Szmatona G; Kaali SG
Fertil Steril; 2008 Dec; 90(6):2133-7. PubMed ID: 18177866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
